All Institut Pasteur articles – Page 2
-
NewsScientists identify window of opportunity for treatment promoting HIV remission
Starting treatment four weeks after infection with HIV promotes long-term control of the virus following the interruption of treatment after two years of antiretroviral therapy.
-
NewsProfessor Yasmine Belkaid takes office as President of the Institut Pasteur
The Institut Pasteur has announced that Professor Yasmine Belkaid took office as its new President on January 2, 2024.
-
NewsNew antibiotics make TB bacterium less pathogenic for humans
Researchers have identified new, antibiotic molecules that target Mycobacterium tuberculosis and make it less pathogenic for humans.
-
NewsProspective study clarifies the role of an innovative metagenomic tool in diagnosing infection
A new study aims to improve use of metagenomics using next-generation sequencing (mNGS) to identify a wide range of pathogens, including rare or novel microorganisms.
-
NewsResearchers to develop vaccine candidates against Marburg viruses
The multidisciplinary European consortium MARVAX will receive 7.4 million euros over the next four years for the research and development of vaccines against Marburg viruses.
-
NewsCovid persistence in lungs linked to failure of innate immunity
A new study shows that SARS-CoV-2 is found in the lungs of certain individuals for up to 18 months after infection, and that its persistence appears to be linked to a failure of innate immunity (the first line of defense against pathogens).
-
News40 years after the discovery of HIV, research raises hopes of remission
The conference ’40 years of HIV science’ was an opportunity to look back at the major advances that are raising hopes of remission and a cure for HIV.
-
NewsSignificant post-COVID resurgence in invasive meningococcal disease
Scientists have traced the evolution of invasive meningococcal disease cases in France between 2015 and 2022, revealing an unprecedented resurgence in the disease after the easing of control measures imposed during the COVID-19 epidemic.
-
NewsInstitut Pasteur and University of Tokyo to form Planetary Health Innovation Center
The Institut Pasteur and the University of Tokyo have signed a letter of intent (LOI) to establish the Planetary Health Innovation Center (PHIC), marking the first step towards the Institut Pasteur of Japan, a private not-for-profit association.
-
NewsGenes fuelling antibiotic resistance in Yemen cholera outbreak uncovered
Widespread antibiotic resistance among cholera-causing bacteria causing the outbreak in Yemen since 2018 explained by gene mixing.
-
NewsMainstay malaria drug may be beginning to fail in the Horn of Africa
In eastern Africa, malaria parasites have developed resistance to artemisinins, the backbone of current treatment regimens, a development that could dramatically worsen malaria’s impact if partner drugs fail in the future.
-
NewsRespiratory tract microbiome influences the severity of bacterial pneumonia
Pneumonia is an infection of the lung alveoli caused by bacteria, viruses or fungi. It is one of the leading causes of morbidity and mortality worldwide, representing a clinical and economic burden and a global public health problem. Source: CDC/ Dr. Francis Chandler Transmission electron microscopic (TEM) image ...
-
NewsScientists discover broadly neutralizing antibodies that contribute to HIV control
Researchers have investigated and revealed how neutralizing antibodies, including those described as broadly neutralizing, contribute to HIV control.
-
NewsGlobal overview of antibiotic resistance determinants yields surprising findings
Scientists have developed a statistical model of the main determinants behind worldwide antibiotic resistance dynamics based on a large-scale spatial-temporal analysis.
-
NewsExtensively drug-resistant Shigella sonnei strain emerges in France
Scientists monitoring Shigella in France have detected the emergence of extensively drug-resistant (XDR) strains of Shigella sonnei. Bacterial genome sequencing and case characteristics suggest that these strains, which originated in South Asia, mainly spread among men who have sex with men.
-
NewsScientists discover unknown circovirus involved in human hepatitis
Scientists have identified a previously unknown species of circovirus, provisionally named human circovirus 1 (HCirV-1).
-
NewsInstitut Pasteur and UCSF QBI team up to create centre of excellence
The Institut Pasteur and UC San Francisco Quantitative Biosciences Institute (UCSF QBI) have announced a new partnership for the joint establishment of the Institut Pasteur-UCSF QBI Center of Excellence in Emerging Infectious Diseases, with planned operations in San Francisco and Paris.
- Previous Page
- Page1
- Page2
- Next Page